Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results

Retina

Volumn 33, Issue 6, 2013, Pages 1232-1240

  Petrarca, Robert ^a,b   Richardson, Matthew ^a   Douiri, Abdel ^b   Nau, Jeffrey ^c   McHugh, Dominic ^a   Stangos, Alexandros N ^a   Jackson, Timothy L ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NeoVista   (United States)

Author keywords

epimacular brachytherapy; indocyanine green angiography; microperimetry; neovascular agerelated macular degeneration

Indexed keywords

RANIBIZUMAB; STRONTIUM 90; YTTRIUM 90;

ADULT; AGED; ARTICLE; BETA RADIATION; BRACHYTHERAPY; BRACHYTHERAPY DEVICE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; EPIMACULAR BRACHYTHERAPY; FEMALE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTERVENTION STUDY; MALE; MICROPERIMETRY; PROSPECTIVE STUDY; RADIATION ATTENUATION; RADIATION INJURY; RADIATION MEASUREMENT; RADIATION RESPONSE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETREATMENT; RISK ASSESSMENT; SENSITIVITY ANALYSIS; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; LINEAR MODELS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION INJURIES; RETINA; SENSORY THRESHOLDS; STRONTIUM RADIOISOTOPES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS; VITRECTOMY; YTTRIUM RADIOISOTOPES;

EID: 84878931253     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182794b22     Document Type: Article

References (30)

1. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-1642. (Pubitemid 15204559)
2. Ávila MP, Farah ME, Santos A, et al. Twelve-month shortterm safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol 2009;93:305-309.
3. Avila MP, Farah ME, Santos A, et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina 2009;29:157-169.
4. Dugel P, Petrarca R, Bennett M, et al. Twelve month safety and feasibility study of epimacular brachytherapy for the treatment of neovascular age-related macular degeneration in subjects treated with chronic anti-vegf therapy: the MERITAGE Study. Ophthalmology 2012;119:1425-1431.
5. Yannuzzi LA, Slakter JS, Sorenson JA, et al. Digital indocyanine green videoangiography and choroidal neovascularization. Retina 1992;12:191-223.
6. Querques G, Tran T, Forte R, et al. Anatomic response of occult choroidal neovascularization to intravitreal ranibizumab: a study by indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 2012;250:479-484.
7. Chen FK, Uppal GS, MacLaren RE, et al. Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration. Clin Exp Ophthalmol 2009;37:275-285.
8. Chen FK, Patel PJ, Xing W, et al. Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Invest Ophthalmol Vis Sci 2009;50:3464-3472.
9. Rohrschneider K, Bultmann S, Springer C. Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog Retin Eye Res 2008;27:536-548.
10. Rohrschneider K, Springer C, Bultmann S, Volcker HE. Microperimetry- comparison between the micro perimeter 1 and scanning laser ophthalmoscope- fundus perimetry. Am J Ophthalmol 2005;139:125-134. (Pubitemid 40094849)
11. Midena E. Microperimetry. Arch Soc Esp Oftalmol 2006;81: 183-186.
12. Varano M, Billi B, Scassa C, et al. Scanning laser ophthalmoscopy in the early diagnosis of vitreoretinal interface syndrome. Retina 1997;17:300-305. (Pubitemid 28070426)
13. Midena E, Radin PP, Pilotto E, et al. Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 2004;19:55-61. (Pubitemid 39658410)
14. Schneider U, Inhoffen W, Gelisken F, Kreissig I. Assessment of visual function in choroidal neovascularization with scanning laser microperimetry and simultaneous indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 1996;234:612-617. (Pubitemid 26340603)
15. Springer C, Bultmann S, Volcker HE, Rohrschneider K. Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology 2005;112:848-854. (Pubitemid 40631504)
16. Jaakkola A, Vesti E, Immonen I. Correlation between Octopus perimetry and fluorescein angiography after strontium-90 plaque brachytherapy for subfoveal exudative age related macular degeneration. Br J Ophthalmol 1998;82:763-768. (Pubitemid 28376905)
17. Soares CG. Calibration of ophthalmic applicators at NIST: a revised approach. Med Phys 1991;18:787-793.
18. Ozdemir H, Karacorlu M, Senturk F, et al. Microperimetric changes after intravitreal bevacizumab injection for exudative age-related macular degeneration. Acta Ophthalmol 2012;90:71-75.
19. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:765-773. (Pubitemid 24355923)
20. Boozalis GT, Schachat AP, Green WR. Subretinal neovascularization from the retina in radiation retinopathy. Retina 1987;7:156-161.
21. Gordon KB, Char DH, Sagerman RH. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys 1995;31:1123-1139.
22. Hanlon J, Lee C, Chell E, et al. Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys 2009; 36:3671-3681.
23. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127:170-177. (Pubitemid 29072557)
24. Stefánsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2009;247:147-163.
25. Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 2001;79:435-440. (Pubitemid 32962830)
26. Krebs I, Brannath W, Glittenberg C, et al. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol 2007;144:741-746.
27. Nomura Y, Ueta T, Iriyama A, et al. Vitreomacular interface in typical exudative age-related macular degeneration and Polypoidal choroidal vasculopathy. Ophthalmology 2011;118:853-859.
28. Lee SJ, Koh HJ. Effects of vitreomacular adhesion on antivascular endothelial growth factor treatment for exudative agerelated macular degeneration. Ophthalmology 2010;118:101-110.
29. Lee SJ, Lee CS, Koh HJ. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am J Ophthalmol 2009;147:621-626.
30. Navarro R, Burés-Jelstrup A, Vásquez L, et al. Radiation maculopathy after epimacular brachytherapy for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Retin Cases Brief Rep 2011;5:352-354.